目的探讨肝炎肝硬化病人的死亡原因。
Objective To investigate the cause of death in patients with posthepatitic cirrhosis.
拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察。
Clinical Observation of Lamivudine for Decompensated Cirrhosis Resulting from Chronic Hepatitis b.
乙型肝炎肝硬化患者肝组织中有较高的HBV复制率；
The results suggest that HBV replication rate were higher in the liver tissues of these patients.
目的探讨卡托普利对早期肝炎肝硬化肝纤维化指标的影响。
Objective to explore the influence of captopril on liver fibrosis index during early-stage viral liver cirrhosis.
方法：101例肝炎肝硬化患者，随机分为治疗组52例。
Method: 101 patients with hepatitis liver cirrhosis were randomly divided into treatment group (52 cases) and control group (49 cases).
目的：探讨茯白方对肝炎肝硬化患者血清胆碱脂酶活力的影响。
Objective: To evaluate the therapeutic effects of Fubai formula on cholinesterase activity in patients with hepatitis related cirrhosis.
急性乙肝患者特异性细胞免疫功能明显强于慢性乙肝患者及肝炎肝硬化患者。
The specific cellular immunity was stronger in the patients with acute hepatitis B than in those with chronic hepatitis B and liver cirrhosis.
目的：用病例对照研究探讨肝炎肝硬化患者发生多重耐药菌感染的危险因素。
Objective: to make an inquiry into the probable risk factors for antibiotic multi-resistance bacterial infection in patients with liver cirrhosis by case-control study.
目的：探讨肝炎肝硬化自发性腹水感染(SAI)患者肠黏膜通透性改变的临床意义。
Aim: To evaluate the changes and clinical significance of intestinal permeability in hepatitis cirrhosis patients with spontaneous ascitic fluid infection (SAI).
结论肝炎肝硬化患者骨髓内环境TPO浓度降低可能是外周血血小板计数减少的原因之一。
Conclusion the marrow fluid TPO concentration decline in hepatitis cirrhotic patients might affect the platelet concentration.
肝炎肝硬化患者合并腹水、大于60岁组合并各种感染的发生率和阴性组比较有显著性差异；
The incidence of infection between groups of ascites, over 60-year age and negative groups had significant difference.
KPTT、HPT及V： C在慢性肝炎、肝炎肝硬化及重症肝炎组与正常组比较均有非常显著差异。
However, HPT has fallen, and has remarkable difference, compared with that in the normal group.
慢性HBV感染导致的肝炎肝硬化和肝癌等终末期肝病，已成为严重危害我国人民生命健康的主要疾病。
Both liver cirrhosis and hepatocarcinoma, which are serious end stage of liver diseases and caused mostly by chronic HBV infection, have been threaten to lives and healthy of Chinese people.
目的：探讨部分脾动脉栓塞术(PSE)治疗肝炎肝硬化门静脉高压症并发脾功能亢进的疗效及临床意义。
AIM: to study the curative effect and clinical significance of the partial spleen artery embolization (PSE) in the treatment of hepatic cirrhosis together with portal hypertension and hypersplenism.
方法对116例肝炎肝硬化患者进行3项心理智能测试及3项脑电诱发电位(ep)检测，并与正常人群比较。
Methods 116 cirrhosis patients were studied by 3 kinds of intelligent mental test and 3 kinds of evoked potential (EP) test, and the results were compared with that of normal population.
结论乙型肝炎肝硬化患者肝移植后预防乙型肝炎复发应采用HBVDNA、YMDD变异及血清标志物联合检测。
Conclusion the combination detection of YMDD variants, HBV DNA and HBV serum markers may define HBV reinfection after liver transplantation in the patients with hepatitis b.
目的分析肝炎肝硬化门静脉高压症脾切除术后门静脉系统形成血栓的相关因素，寻找预防门静脉高压症脾切除术后门静脉系统形成血栓的方法。
Objective to analyze the relevant factors and explore methods for prevention of portal vein thrombosis in patients after splenectomy for portal hypertension due to cirrhosis resulting from hepatitis.
结论华蟾素注射液穴位注射治疗活动性肝炎肝硬化通过抑制乙肝病毒复制、保护肝细胞等作用，明显控制肝炎肝硬化的炎症活动，安全无不良反应。
Conclusion Intra-acupoint injection of cinobufacin can inhibit viral replication, protect liver cells and control inflammation, It is safe and effective without significant side effect.
长出“人”肝脏的老鼠可用来研究疟疾、肝炎和肝硬化疾病的治疗。
MICE with a "human" liver could be used to study malaria, hepatitis and cirrhosis.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
肝炎的程度从轻微到致命，而且最终可能会导致肝硬化。
The degree of liver inflammation can range from mild to deadly, and cirrhosis of the liver can result.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
结论：胆囊壁的声像改变对肝炎、肝硬化患者肝实质损伤严重程度的判断以及指导临床治疗具有重要意义。
Conclusions: Ultrasonography of the gallbladder-wall changings plays an important role in judging the severity of liver parenchyma and guiding treatment of hepatitis and liver cirrhosis patients.
丙肝病毒可以导致慢性肝炎，肝硬化，肝细胞肝癌或原发性肝癌。
HCV infection can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC) or primary liver cancer.
慢性肝炎与肝硬化有什么区别？
What distinction do chronic hepatitis and liver cirrhosis have?
肝病包括黄疸、肝炎、肝硬化、肿瘤、血管阻塞、脓疮和肝糖贮积病。
Liver disorders include jaundice, hepatitis, cirrhosis, tumours, vascular obstruction, abscess, and glycogen-storage diseases.
结果：绝大多数肝炎、肝硬化患者胆囊壁具有不同程度变化：毛糙、增厚、水肿。
Results: gallbladder-wall of most hepatitis and liver cirrhosis patients had been changed, including: coarse, thickening and hydrops.
应用ria法检测了62例慢性肝炎和肝硬化患者基础血清催乳素(PRL)和雌二醇(E_2)的浓度。
The concentrations of basal serum prolactin (PRL) and estradiol (E_2) of 62 cases of chronic hepatitis and hepatocirrhosis were determined by RIA method.
胃肠舒对肝炎后肝硬化患者的胃动力障碍有较好的治疗作用。
Weichangshu has a better therapeutic action on gastric motility disorder in the patient of hepatocirrhosis after hepatitis.
胃肠舒对肝炎后肝硬化患者的胃动力障碍有较好的治疗作用。
Weichangshu has a better therapeutic action on gastric motility disorder in the patient of hepatocirrhosis after hepatitis.
应用推荐